Hvivo Share Discussion Threads

[spurs777] 22/10/2018 19:58

10k down and never been so relaxed, watch all these gas bill payers who are in arrears will buy in when it's starts moving up just to clear there arrears!

[discojames] 22/10/2018 19:03

These clowns are only looking for a cheaper entry point, you see it all the time. Watch them change their standing as fast as their mum changes customers, when they buy in

[bernymadoff] 22/10/2018 17:30

Prepared to wait. We'll see who has the last laugh here in a few months time. In the meantime while we await flu-v updates there's lots more big contract news to look forward to and the malaria P1 results. Still very relaxed here.

[mister md] 22/10/2018 15:33

44p on the bid, this is declining even faster than expected now

[a1samu] 22/10/2018 15:15

Depends on the beer. Not if best bitter, which this is turning into more and more, with no sign anywhere of the knight in shining armour, the JV champion of the major pharma.!

[mister md] 22/10/2018 15:04

I suppose beer money is preferable to crying into your beer ...
Something still doesn't smell right here, "the market" is usually right ...

[bernymadoff] 18/10/2018 11:51

Not here to make beer money like you prats. This is a biotech seeking to make the leap to JV with major pharma. It's not a day trade. I'm happy to wait a few months for the story to play out.

[stealive] 18/10/2018 09:40

Hopefully seller gone. Now too the mooooonnnn.

[mister md] 18/10/2018 09:24

200k and 100k dumped at 49p

yet another buying opportunity for Berny ! Will he be able to turn his losing position around ?

[a1samu] 17/10/2018 15:35

Yea, berny is all on his own when woody panic sells out, with just the other 90% of losers.

[mister md] 17/10/2018 13:52

Just Woody and Berny in this now ...

[a1samu] 17/10/2018 13:49

This is a typical share for mug investors, ( the 90% ), who lose money all the time and with berny constantly ramping he is just drawing in more losers!

[bernymadoff] 17/10/2018 13:44

If it's any guide the last time the share price was at 50p it promptly went on to do over 100%. Just saying

[a1samu] 17/10/2018 09:44

Berny who are you rumping for? The fluctuations in this share are not ordinary!

This share only goes one way because of the lack of credibility of the directors and the lack of purpose and direction and lack of prospects of the company!

This is a typical share for mug investors, ( the 90% ), who lose money all the time and with your constant ramping you are just drawing in more losers!

[bernymadoff] 16/10/2018 19:57

Nothing much makes sense at the moment with this stock. But its definitely not Woody selling. He only just increased his stake to 29%. The story hasn't changed so daily fluctuations should be ignored. Personally I suspect someone has let go of £500k and the stock has been taken up by another willing party.

[headancer] 16/10/2018 19:46

After that 500k sale the price went up.Why ?
Was it a sell ?

I accept it should have gone down, it didn't.

80% of this share is with institutions, nothing has changed in 12 weeks when Woodford was cleaning up,

I genuinely cannot see why Woodford WOULD take a 30% stake 2 week ago and suddenly say today
Tell you what..nah lets not bother.

I may be wrong but is something afoot?

It makes no sense.

[spurs777] 16/10/2018 18:21

Some food for thought 90% of investors lose money on aim in their first year of trading. 72% of companies dilute the shares till they worth F all for shareholders and eventually when they fail in their attempts to raise anymore they shut shop. It's aim we playing with my 15k in HVO that I bought at 81.50 might as well say goodbye ? over the next coming weeks this will drop back down to 40 maybe 30s with a 500k come on guys it's only going one way and that's f ing down angry absolutely why shouldn't I be with all the hype dead hype

[a1samu] 16/10/2018 17:35

500,000 shares changed hands today 16 October at lunchtime @50p each in four lots!

[bernymadoff] 16/10/2018 13:30

Just been checking on the news we are expecting this quarter. We know there are more contracts in the pipeline as was stated in the interims.

The Flu-V commercialisation news is the big one as we all know but the timing of any updates is just too much of an unknown to predict with any degree of accuracy. There is however the full results from NiH Flu-V 004 challenge study which according to the NiH website was completed on May 25th 2018. I would imagine these could land at any time.

The other important news is the AGS-v malaria vaccine P1 trial results. According to the NiH website the primary completion date for the study is estimated to be 30 Oct 2018. I expect some results to be released shortly after this date. The final completion date is Aug 1, 2019 but my understanding is that this second stage of the study is to assess the safety aspect of the trial (participants will be asked to go back 10 months after the trial to assess long-term safety of the anti-malaria vaccine. You can read this for yourself here:

hxxps://www.niaid.nih.gov/news-events/nih-begins-study-vaccine-protect-against-mosquito-borne-diseases

And you can see the timeline here:

hxxps://clinicaltrials.gov/ct2/show/results/NCT03055000

Based on this info I would assume that the efficacy part of the vaccine trial has been more or less completed by now and that HVO will have some idea of whether it works or not. That is why I find the following statement from the recent interims very intriguing.

"As previously announced, the Board of Imutex is exploring strategic alternatives with regards to both assets, including but not limited to a full sale, a licensing agreement or a non-dilutive funding arrangement with a collaborator to run the Phase III development and study for the FLU-v vaccine candidate. Any material information regarding discussions or about the Imutex assets will be announced as appropriate."

To my mind the company has never communicated any exploration of strategic alternatives for AGS-V. If it has I certainly can't find any. In any event why would they mention commercialising it in the same breath as Flu-V unless they knew it worked? If the P1 trial was unsuccessful there would be no reason to talk about it with the majors but the fact that the company are apparently in discussions suggests to me that they are onto another winner here.

At the bottom of the first link I have posted it states: "Throughout the trial, an independent Data and Safety Monitoring Board will review study data to evaluate participant safety and the overall conduct of the study. A medical monitor from NIAID’s Office of Clinical Research Policy and Regulatory Operations will also perform routine safety assessments."

So analysis of the data is ongoing throughout the trial and HVO will have knowledge of efficacy. For HVO to have written in their interims that they are exploring strategic alternatives for AGS-v is a strong sign that the AGS-V vaccine trial will be reported successful.

[bernymadoff] 15/10/2018 18:43

Yep never look a gift horse in the mouth. The trouble with staring at the share price every few mins is that you end up making your trading decisions on the immediate direction of movement. I've always said I'm not here for a few percent. Neither are the big boys or the directors who are all well positioned to.take advantage of the coming upside. Biotech is not a quick turnaround business so from the outset I expected Flu-v commercialisation to take 6 to 9 months. Nothing in the bigger story has changed. If anything it has just got better with the £21m contracts. Sit tight wait and accumulate if you want multibag returns. Unfortunately the trouble with most PIs is that they follow the herd mentality and buy as the share price is rising instead of loading up on the dips when it is drifting. I only bought £750 today as that's all the loose change I had left but it's a no brainer down here.

[spurs777] 15/10/2018 13:54

It's going back down to 40 then will shoot up again!

[mister md] 15/10/2018 13:37

Bernymadoff must be rubbing his hands with glee at yet another opportunity to average down